Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for braf protein, human (compound)
Most Correlated Studies
- Melanoma cells Ras or BRAF mutant treated with sorafenib and/or diclofenac
- Antitumor efficacy of GDC-0879 involving BRAF mutational status
- Response to TNF-alpha in melanoma cell lines with different mutations
- Gene expression in response to chemotherapy in human-melanoma cells
- Uveal melanoma cell lines reponses to selumetinib treatment
Most Relevant Literature
- BRAF V600E mutated metastatic colorectal cancer: current progress and future directions.
- Targeting BRAF-mutant glioma: reflections on the ROAR trial.
- BRAF inhibitors-induced paradoxical reactions and oncogenesis].
- BRAF: a biomarker not to be missed in glioblastoma.
- Myocarditis as a manifestation of Erdheim-Chester Disease: successful use of anti- IL1 and BRAF inhi…
Most Relevant Clinical Trials
- Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations
- Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Dis…
- HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma
- GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
- Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations
